CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
prostatectomy and lymph node dissection for biopsy confirmed prostate cancer.The U.S. Food and Drug Administration (FDA) has approv...
Phase 2
Indianapolis, Indiana, United States and 2 other locations
This is a randomized pilot study of Coronary CT Angiography (CCTA) for coronary atherosclerosis vs. Usual Care in patients with prostate cancer...
Indianapolis, Indiana, United States
This is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I\&T injection for PET/CT imaging in patients with recurrent prostate...
Phase 3
Indianapolis, Indiana, United States and 30 other locations
This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...
Phase 3
Greenwood, Indiana, United States and 107 other locations
Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...
Phase 3
Indianapolis, Indiana, United States and 34 other locations
This is a phase 1 study to assess the safety and tolerability of ARX517 in adult subjects with Metastatic Castration-Resistant Prostate Cancer...
Phase 1
Indianapolis, Indiana, United States and 8 other locations
Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...
Phase 1
Indianapolis, Indiana, United States and 50 other locations
Initial performance of Ga-68-P16-093 in prostate cancer patients including dosimetry and preliminary efficacy evaluation in BCR pat ...
Phase 1, Phase 2
Indianapolis, Indiana, United States
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Carmel, Indiana, United States and 388 other locations
pharmacodynamics, and preliminary efficacy of AZD5305 when given in combination with new hormonal agents (NHAs) in patients with Metastatic Prostate...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 26 other locations
Clinical trials
Research sites
Resources
Legal